BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• ARIUS Research Inc. Closes Financing

  December 14, 2005

   · 

  1 min read
• Business

  Depomed, Inc. And Biovail Corporation Revise Partnership Agreement For Development, Commercialization Of Glumetza (Tm)

  December 14, 2005

   · 

  1 min read
• Drug Development

  Nuvelo, Inc. Receives Special Protocol Assessment For Phase 3 Trial Of Alfimeprase In Acute Peripheral Arterial Occlusion

  December 14, 2005

   · 

  7 min read
• Business

  Light Sciences Oncology, Inc. Completes Second Closing In $67 Million Financing For Late Stage Development Of Litx(TM)

  December 14, 2005

   · 

  1 min read
• Biotech Bay

  Maxygen, Inc. To Host 2005 Year End Conference Call On December 15, 2005

  December 14, 2005

   · 

  1 min read
• Policy

  U.S. FDA Staff Cite Merck & Co., Inc. Shingles Vaccine Zostavax Limits; Did Not Significantly Affect Rates Of Death Or Hospitalization; Vaccine Less Effective After Three Years

  December 14, 2005

   · 

  1 min read
• Genetown

  Alnylam Pharmaceuticals Announces Pandemic Flu As Next Development Program

  December 14, 2005

   · 

  1 min read
• Business

  Pfizer Inc. To Finance $100 Million Safety Study Of Celebrex

  December 14, 2005

   · 

  1 min read
• Drug Development

  SciClone Pharmaceuticals, Inc. And Sigma-Tau Pharmaceuticals Report Promising Interim Phase 2 Results In Advanced-Stage Malignant Melanoma Trial

  December 14, 2005

   · 

  1 min read
• Drug Development

  GroPep Limited Changes Track From Psoriasis Drug To Asthma

  December 14, 2005

   · 

  1 min read